Changing Fortunes in the Obesity Treatment Industry

November 30, 2011
15 Views

With Qnexa, Contrave and Lorcaserin each recently rejuvenated after previous FDA’s near-death sentences, the market outlook for obesity drugs is now being viewed almost as optimistically as it was in 2010.

With Qnexa, Contrave and Lorcaserin each recently rejuvenated after previous FDA’s near-death sentences, the market outlook for obesity drugs is now being viewed almost as optimistically as it was in 2010.

Devices for the treatment of obesity are on the market, aggressively promoted (to a fault) and therefore driving revenue growth for manufacturers.  Much of this growth, however, comes in the vacuum left by clinical effective obesity drugs.  Devices are not without complications (see “1-800-GET-THIN”) and the need for surgery, even increasingly less invasive, is an impediment to more widespread use.  Long term data suggests a higher than anticipated need for repeat procedures, but this is not a significant disadvantage relative to obesity drugs, which must be taken indefinitely to maintain weight levels.

The global market for obesity drugs and devices will largely follow patterns in the Americas in general, or the U.S. in particular.  Below is illustrated the 2009 to 2019 market in the Americas for obesity drugs and devices, reflecting specific anticipated market developments (see report #S835) during that time.

Source: “Products, Technologies and Markets Worldwide for the Clinical Management of Obesity, 2011-2019.” Report #S835, MedMarket Diligence, LLC

     

You may be interested

3 Surprising Facts About the American Healthcare System
Health care
0 shares229 views
Health care
0 shares229 views

3 Surprising Facts About the American Healthcare System

Ryan Kh - May 24, 2017

The status of American healthcare has been in the news frequently over the past several months due to the new…

SEO vs Paid Search vs Social Media – Which is Better for Healthcare Marketing
eHealth
0 shares381 views
eHealth
0 shares381 views

SEO vs Paid Search vs Social Media – Which is Better for Healthcare Marketing

Rehan Ijaz - May 23, 2017

Digital media has transformed marketing practices in just about every industry. Healthcare marketing has surprisingly been affected by the digital…

New Protein Could Aid in Therapy for Mesothelioma
Medical Innovations
0 shares2057 views
Medical Innovations
0 shares2057 views

New Protein Could Aid in Therapy for Mesothelioma

jennacyprus - May 22, 2017

In the world of oncology, there’s a common consensus that cancer rarely has a single cause. Instead, the majority of…